A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Popularity Online
Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid British shipping. Vendors promote the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Voice Worries
However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.
Several experts said the popularity for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer laws, risking penalties, legal action or imprisonment.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The organization stated it was committed to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display dark colored packages with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly significant medical dangers”.
